EUVIMEDFaigh amach EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

Contact dermatitis from cera alba in a lip balm—An overlooked allergen?

Sharan Kapadia iD, Alpa Kanji, Sarah H Wakelin

Contact Dermatitis · 2023-04 · 88 (4) · 324-325

DOI: 10.1111/cod.14273 ↗

At a glance

Fallbericht in Contact Dermatitis, published online on 2023-01-19. Written by Sharan Kapadia and 2 co-authors. Institution: Imperial College School of Medicine, London, UK. Major MEDLINE topics: Dermatitis, Allergic Contact, Cheilitis. Cited 4 times so far (Crossref); 6 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AchoimreSubjectsSonraí leabharliostaCiteRelated studies

Abstract (original language)

We report a case of contact allergy to cera alba (white beeswax) presenting as relapsing cheilitis in a young woman. There have been isolated reports of allergic contact dermatitis from cera alba.1, 2 Because it is widely used in lip balms, and easily overlooked, we recommend its inclusion in a lip allergen series. A 29-year-old woman with nut allergy and asthma was referred for assessment of chronic, relapsing cheilitis and peri-oral dermatitis (Figure 1). She had also had an episode of acute infected facial dermatitis, which she attributed to use of a paper face mask. She had used various lip balms, including Carmex and Cicaplast Levres, without improvement. She was patch tested to the extended British baseline series, fragrances, flavourings, a cosmetic and toiletry series, and her own lip cosmetics. Allergens were obtained from Chemotechnique (Vellinge, Sweden) and applied on Smart Practice allergEAZE chambers (Arizona, USA). Readings done on day 2 and day 4 (according to ESCD criteria) revealed multiple allergies (Table 1), mostly to fragrances but also to her Cicaplast Levres lip balm. The lip balm was not fragranced and did not contain any of the other identified allergens, so ingredient testing was indicated. The manufacturers, La Roche-Posay, kindly provided ingredients at recommended concentrations.3 Ingredient testing confirmed an allergic reaction to the lip balm and to cera alba 30% petrolatum by day 4 (Table 1, Figure 2). Her symptoms improved on allergen avoidance. Patch testing of cera alba 30% petrolatum and Cicaplast Levres lip balm in 20 control patients was negative. Cera alba (“white beeswax”) is commonly used in cosmetics and medicaments, especially lip balms. It may be obtained from raw cera flava (“yellow beeswax”)4 via melting to remove impurities such as propolis and pollen,5 removal of aroma components, and/or bleaching (e.g., with hydrogen peroxide), although the chemical distinction between cera alba and cera flava is not exact.4 There appear to be no maximum residue limits for cosmetic- or pharmaceutical-grade beeswax.5 Contact allergy to cera alba has been reported1, 2 though it appears relatively rare. A 2009 patch testing study on a general patient population noted allergy in only 3 (0.1%) of 2828 patients.6 However, a different study, which only included patients with cheilitis or facial dermatitis, reported that 9 (18.4%) of 49 patients were allergic to cera alba4; this suggests that although rare in the general population, cera alba allergy may be an important culprit among those affected by facial contact dermatitis. Interestingly, 16 (16.8%) of 95 patients reacted to cera flava, usually the commoner allergen. Only one patient was allergic to cera alba but not cera flava.4 Most beeswax-allergic patients were also propolis-allergic, suggesting these bee products may contain shared allergens.5, 6, 4 However, our patient was not allergic to propolis (tested as propolis cera 10% pet); it remains unclear whether contact allergy to cera alba is attributable to contamination with propolis.4 The precise haptens in cera alba and cera flava have yet to be elucidated but are being studied; for example, Nyman et al. used mass spectrometry and patch testing to show that caffeic acid was higher in cera flava than cera alba but was unlikely to be a contributory hapten.4 Since beeswax products such as cera alba and cera flava are naturally derived, it is possible that place of origin as well as extent and method of purification may introduce slight variations in the composition of samples and therefore influence patch testing results. For example, the beeswax of different bee species varies,5 and variations in chemical and/or mechanical purification approaches (such as melting temperature, hydrogen peroxide concentration, citric and oxalic acid usage, complexing agent usage) could yield cera alba of varying compositions.5 Therefore, in addition to further clinical patch testing studies investigating allergy to cera alba among cheilitis patients, laboratory work identifying the precise chemical composition and haptens of various beeswax products from different suppliers would provide valuable evidence; this may enable more specific categorisation of beeswax products and more standardized patch testing. As demonstrated by Nyman et al., mass spectrometry and other analytical tools may prove useful for this purpose.4 In summary, this case highlights the importance of testing patients to their own products and the value of ingredient testing. Allergy to cera alba in lip balms should be considered in patients with relapsing cheilitis. Nyman et al. suggested adding cera alba, cera flava, and propolis to patch test series for patients with cheilitis4; our case supports this. Sharan Kapadia: Conceptualization; writing – original draft; visualization; writing – review and editing. Alpa Kanji: Investigation; writing – review and editing. Sarah Wakelin H: Conceptualization; investigation; methodology; writing – review and editing; supervision. The authors declare no conflicts of interest.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactCheilitisHumansAllergensLipPatch Tests

Author keywords

allergic contact dermatitiscase reportcera alba (CAS no. 812-89-3)cheilitis

Substances

Allergens

Authors and institutions

  • Imperial College School of Medicine, London, UK.
  • Department of Dermatology, Imperial College Healthcare Trust, London, UK.

ORCID profiles: Sharan Kapadia

Cite

APA

Kapadia, S., Kanji, A., & Wakelin, S. H. (2023). Contact dermatitis from cera alba in a lip balm—An overlooked allergen?. Contact Dermatitis, 88(4), 324-325. https://doi.org/10.1111/cod.14273

Vancouver

Kapadia S, Kanji A, Wakelin SH. Contact dermatitis from cera alba in a lip balm—An overlooked allergen?. Contact Dermatitis. 2023;88(4):324-325. doi:10.1111/cod.14273

BibTeX
@article{Kapadia2023,
  author = {Kapadia, Sharan and Kanji, Alpa and Wakelin, Sarah H},
  title = {Contact dermatitis from cera alba in a lip balm—An overlooked allergen?},
  journal = {Contact Dermatitis},
  year = {2023},
  volume = {88},
  number = {4},
  pages = {324--325},
  doi = {10.1111/cod.14273}
}
Start for free →